Multiple Therapeutic Applications of RBM-007, an Anti-FGF2 Aptamer
Vascular endothelial growth factor (VEGF) plays a pivotal role in angiogenesis, but is not the only player with an angiogenic function. Fibroblast growth factor-2 (FGF2), which was discovered before VEGF, is also an angiogenic growth factor. It has been shown that FGF2 plays positive pathophysiologi...
Main Author: | Yoshikazu Nakamura |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/7/1617 |
Similar Items
-
Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
by: Tatsuo Adachi, et al.
Published: (2019-11-01) -
Aptamers in Therapeutics
by: Abhishek Parashar
Published: (2016-06-01) -
Aptamer Therapeutics in Cancer: Current and Future
by: Yoshihiro Morita, et al.
Published: (2018-03-01) -
Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins
by: Perepelyuk M, et al.
Published: (2016-07-01) -
Development of HER2-Specific Aptamer-Drug Conjugate for Breast Cancer Therapy
by: Hwa Yeon Jeong, et al.
Published: (2020-12-01)